To the extent possible under law, the person who associated CC0 with this work has waived all copyright and related or neighboring rights to this work.
DRAVP ID DRAVPa2174
Peptide Name Sequence 5 from Patent US20230256049A1
Sequence KFDSLVECIWDWIDRLWS
Sequence Length 18
Source Synthetic peptide
Target Organism SARS-CoV-2
Patent Type Patent Application
Publication Date 2023-08-17
Patent No US20230256049A1
Family Info WO2022020766A1, EP4171746A4, CA3186948A1
Patent Title Materials and methods for the prevention and treatment of viral respiratory diseases
Comment
Abstract This disclosure is related to the use of a peptide with antimicrobial properties. The peptide is administered topically via nasal or pulmonary delivery to prevent or treat respiratory diseases caused by viruses. A variety of formulations and uses are described as well as methods of manufacture thereof. The formulations are safe and useful in patients—both humans and animals—for the delivery of appropriate bioactive substance(s) to the respiratory system.
To the extent possible under law, the person who associated CC0 with this work has waived all copyright and related or neighboring rights to this work.